title: [Peritoneal dialysis: peritonitis and catheter infections].
abstract: Infections were reviewed among 118 patients (M = 64, F = 54) undergoing peritoneal dialysis (PD) from 01-86 to 12-91. One hundred and fifty-five catheters were installed during the study period. Twenty-seven (23%) had more than one catheter. Forty-seven patients (39.8%) were diabetics. Mean follow-up was 460 days per catheter and 540 days per patient. Factors were collected and analyzed by multiple logistic regression. Survival curves were drawn according to the Kaplan-Meyer method. One year survival was 73.8%. Respective incidence of the different infections are presented. Fourteen percent of peritonitis, 48% of tunnel infections and 2.1% of exit site infections led to catheter removal. Younger patients had more catheter infections (p < 0.05). The different types of infections were significantly influenced by the system of dialysis employed (p < 0.005). Perioperative antibiotic coverage diminished the incidence of peritonitis during the first three months (p < 0.05). With our data and our literature review, we have attempted to make some recommendations in order to reduce the occurrence of infections under PD.
authors.affiliation: Service de Néphrologie, Hôpital du Sacré-Coeur de Montréal, Québec, Canada.
authors.forename: E
authors.initials: E
authors.lastname: Bergeron
authors.forename: R
authors.initials: R
authors.lastname: Denis
authors.forename: P
authors.initials: P
authors.lastname: Cartier
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology* / Q000628:therapy; D002408:Catheters, Indwelling / Q000009:adverse effects*; D003428:Cross Infection / Q000209:etiology* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009181:Mycoses / Q000209:etiology* / Q000628:therapy; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000295:instrumentation; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology*; D012189:Retrospective Studies
chemical_list: D000900:Anti-Bacterial Agents